NCT05982847

Brief Summary

The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22,464

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Apr 2024

Longer than P75 for all trials

Geographic Reach
2 countries

11 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Apr 2024Nov 2028

First Submitted

Initial submission to the registry

August 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 9, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2028

Last Updated

September 5, 2024

Status Verified

September 1, 2024

Enrollment Period

4.7 years

First QC Date

August 1, 2023

Last Update Submit

September 4, 2024

Conditions

Keywords

AdiposityBlood PressureCardiovascular DiseasesHealth Knowledge, Attitudes, PracticeLifestyle Factors

Outcome Measures

Primary Outcomes (3)

  • To determine and compute nationally representative normative reference values for blood pressure in children

    To date there are no national normative blood pressure reference values for children in South Africa. Normative values used by clinicians are those extrapolated from studies on blood pressure done in the USA and Europe and these may not be truly representative of normative values of blood pressure in South Africa. This study aims to address this issue, because children can be misdiagnosed for high blood pressure based on the wrong normative values.

    Through study completion, an average of 1 year

  • To determine and compute nationally representative normative reference values for blood pressure in children

    Overweight and obesity classification according to the World Health Organisation percentiles for childhood obesity only include a small sample size from less than five African countries, therefore the underrepresentation of children of African ancestry will be addressed by this study.

    Through study completion, an average of 1 year

  • To develop clinical practice guidelines for the management of childhood hypertension in South Africa

    The findings of this study will help develop clinically relevant guidelines for the management of hypertension in children between 5 and 18 years of age based on local normative values, as well as to improve cost and availability of anti-hypertensive agents for children and adolescents.

    Through study completion, an average of 1 year

Study Arms (2)

Boys

Diagnostic Test: Blood pressure screening

Girls

Diagnostic Test: Blood pressure screening

Interventions

Blood pressure and anthropometric measurements will be performed in children and adolescents between ages 5-18 years to develop South African nomograms that will aid in the development of clinical practice guidelines to optimise hypertension care in South Africa youth.

Also known as: Anthropometric measurements
BoysGirls

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

The target population for this study includes 5 to under 18 years school-aged children in South Africa from all provinces in the country selected in a randomized manner and to ensure generalizability. All South African public ordinary schools are categorised into five groups, called quintiles, largely for purposes of the allocation of financial resources from government. Quintile one is the lowest socioeconomic quintile, while quintile five is the highest. In addition, lower quintile schools are mostly rural and/or peri-urban. Participants will be drawn from quintile 1-5 schools and those in more remote areas will be reached via mobile fieldwork teams. A sample of 22 464 (81% Black African; 9% Coloured; 8% White and 2% Indian/Asian) will be required to enable computation of reference values for each age and sex across urban and rural settings in all provinces.

You may qualify if:

  • All children between ages 5-\<18 years
  • All children with voluntary assent/consent and parent's permission

You may not qualify if:

  • circumstances interfere with the participant's ability to give informed consent (diminished understanding or comprehension, or any language barriers that may pose potential risk in participation under false expectations)
  • randomly selected children who choose not to participate (lack of assent/consent), even if parent's permission was received,
  • conditions that interfere with a patient's ability to follow study guidelines, e.g., the use of drugs, alcohol or tobacco products
  • ages \>18 years or under 5 years
  • Children will be excluded from the analysis for the determination of normative reference values for blood pressure and anthropometry if taking certain concomitant medication(s) that may affect their blood pressure, or any underlying disease e.g., chronic kidney disease, chronic heart disease etc. that may raise blood pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Walter Sisulu University

Mthatha, Eastern Cape, South Africa

NOT YET RECRUITING

Nelson Mandela Metropolitan University

Port Elizabeth, Eastern Cape, South Africa

RECRUITING

University of the Free State

Bloemfontein, Free State, South Africa

RECRUITING

University of the Witwatersrand

Johannesburg, Gauteng, South Africa

RECRUITING

University of KwaZulu-Natal

Durban, KwaZulu-Natal, South Africa

NOT YET RECRUITING

University of Limpopo

Polokwane, Limpopo, South Africa

NOT YET RECRUITING

Hypertension in Africa Research Team (HART), North-West University

Potchefstroom, North West, 2531, South Africa

RECRUITING

Red Cross War Memorial Children Hospital

Cape Town, Western Cape, South Africa

NOT YET RECRUITING

South African Medical Research Council

Cape Town, Western Cape, South Africa

NOT YET RECRUITING

University of Cape Town

Cape Town, Western Cape, South Africa

NOT YET RECRUITING

University of Zurich

Zurich, Switzerland

NOT YET RECRUITING

MeSH Terms

Conditions

HypertensionPediatric ObesityObesityCardiovascular DiseasesBehavior

Condition Hierarchy (Ancestors)

Vascular DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Ruan Kruger, PhD

CONTACT

Lebo F Gafane-Matemane, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 1, 2023

First Posted

August 9, 2023

Study Start

April 1, 2024

Primary Completion (Estimated)

November 30, 2028

Study Completion (Estimated)

November 30, 2028

Last Updated

September 5, 2024

Record last verified: 2024-09

Locations